Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DECIPHER LABS vs ABBOTT INDIA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DECIPHER LABS ABBOTT INDIA DECIPHER LABS/
ABBOTT INDIA
 
P/E (TTM) x -2.1 50.0 - View Chart
P/BV x 0.6 18.2 3.5% View Chart
Dividend Yield % 0.0 1.2 -  

Financials

 DECIPHER LABS   ABBOTT INDIA
EQUITY SHARE DATA
    DECIPHER LABS
Mar-23
ABBOTT INDIA
Mar-23
DECIPHER LABS/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs6322,482 0.3%   
Low Rs1416,156 0.1%   
Sales per share (Unadj.) Rs45.12,517.0 1.8%  
Earnings per share (Unadj.) Rs-2.7446.8 -0.6%  
Cash flow per share (Unadj.) Rs-2.2479.7 -0.5%  
Dividends per share (Unadj.) Rs0325.00 0.0%  
Avg Dividend yield %01.7 0.0%  
Book value per share (Unadj.) Rs23.01,480.5 1.6%  
Shares outstanding (eoy) m10.1021.25 47.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.97.7 11.1%   
Avg P/E ratio x-14.543.2 -33.5%  
P/CF ratio (eoy) x-17.340.3 -42.9%  
Price / Book Value ratio x1.713.0 12.8%  
Dividend payout %072.7 -0.0%   
Avg Mkt Cap Rs m389410,513 0.1%   
No. of employees `000NANA-   
Total wages/salary Rs m4125,636 7.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m45653,487 0.9%  
Other income Rs m741,543 4.8%   
Total revenues Rs m52955,030 1.0%   
Gross profit Rs m-10612,055 -0.9%  
Depreciation Rs m4700 0.6%   
Interest Rs m5160 3.0%   
Profit before tax Rs m-4212,738 -0.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-153,244 -0.5%   
Profit after tax Rs m-279,494 -0.3%  
Gross profit margin %-23.322.5 -103.4%  
Effective tax rate %35.525.5 139.4%   
Net profit margin %-5.917.8 -33.2%  
BALANCE SHEET DATA
Current assets Rs m20130,251 0.7%   
Current liabilities Rs m5012,060 0.4%   
Net working cap to sales %33.234.0 97.6%  
Current ratio x4.12.5 161.6%  
Inventory Days Days3087 34.7%  
Debtors Days Days7892 36,490.4%  
Net fixed assets Rs m7115,135 0.5%   
Share capital Rs m101213 47.5%   
"Free" reserves Rs m13131,248 0.4%   
Net worth Rs m23231,460 0.7%   
Long term debt Rs m00-   
Total assets Rs m27245,386 0.6%  
Interest coverage x-7.680.7 -9.5%   
Debt to equity ratio x00-  
Sales to assets ratio x1.71.2 142.4%   
Return on assets %-8.121.3 -38.1%  
Return on equity %-11.630.2 -38.3%  
Return on capital %-15.841.0 -38.7%  
Exports to sales %00.4 0.0%   
Imports to sales %010.8 0.0%   
Exports (fob) Rs mNA221 0.0%   
Imports (cif) Rs mNA5,765 0.0%   
Fx inflow Rs m0310 0.0%   
Fx outflow Rs m05,818 0.0%   
Net fx Rs m0-5,508 -0.0%   
CASH FLOW
From Operations Rs m-168,934 -0.2%  
From Investments Rs m-43-1,477 2.9%  
From Financial Activity Rs m-22-6,387 0.3%  
Net Cashflow Rs m-801,070 -7.5%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 16.4 75.0 21.9%  
Indian inst/Mut Fund % 0.0 8.9 -  
FIIs % 0.0 0.2 -  
ADR/GDR % 0.0 0.0 -  
Free float % 83.6 25.0 334.1%  
Shareholders   34,511 72,252 47.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DECIPHER LABS With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on COMBAT DRUGS vs Abbott India

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

COMBAT DRUGS vs Abbott India Share Price Performance

Period COMBAT DRUGS Abbott India S&P BSE HEALTHCARE
1-Day 0.68% 0.74% 1.18%
1-Month -17.62% -5.97% -0.75%
1-Year -1.07% 24.80% 61.82%
3-Year CAGR -24.12% 21.40% 18.16%
5-Year CAGR -10.83% 29.91% 19.79%

* Compound Annual Growth Rate

Here are more details on the COMBAT DRUGS share price and the Abbott India share price.

Moving on to shareholding structures...

The promoters of COMBAT DRUGS hold a 16.4% stake in the company. In case of Abbott India the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of COMBAT DRUGS and the shareholding pattern of Abbott India.

Finally, a word on dividends...

In the most recent financial year, COMBAT DRUGS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

Abbott India paid Rs 325.0, and its dividend payout ratio stood at 72.7%.

You may visit here to review the dividend history of COMBAT DRUGS, and the dividend history of Abbott India.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.